Nymbl Science
Offers balance and bladder health training through digital programs for older adults.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | $1.6m Valuation: $60.0m | Late VC | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 13 % | 56 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Nymbl Science operates in the healthcare sector, focusing on digital mobility solutions aimed at reducing fall-related medical costs. The company serves health plans and their members by providing a platform that guarantees cost savings of $3 PMPM and a 3:1 return on investment. Nymbl Science's methodology identifies the risk levels of potential fallers and intervenes before a medically-diagnosed fall occurs. This proactive approach not only reduces medical costs but also increases STAR ratings across HOS scores and boosts member retention. The business model revolves around offering a subscription-based service to health plans, with fees at risk to prove their cost-saving claims. Revenue is generated through these subscriptions, which are justified by the tangible cost savings and improved health outcomes for members.
Keywords: digital mobility, healthcare, fall prevention, cost savings, ROI, STAR ratings, member retention, health plans, risk assessment, subscription service.